Literature DB >> 25583800

How does multistep tumorigenesis really proceed?

Christine L Chaffer1, Robert A Weinberg2.   

Abstract

Identifying the cancer cells-of-origin is of great interest, as it holds the potential to elucidate biologic mechanisms inherent in the normal cell state that have been co-opted to drive the oncogenic cell state. An emerging concept, proposed here, states that cancer stem cells, key players in cancer initiation and metastasis, arise when transit-amplifying cells with mutant genomes dedifferentiate and enter the stem cell state. This model contrasts with the notion that cancer stem cells are the direct products of neoplastically transformed normal tissue stem cells. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25583800      PMCID: PMC4295623          DOI: 10.1158/2159-8290.CD-14-0788

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  10 in total

1.  Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.

Authors:  Kaijie He; Tong Xu; Amir Goldkorn
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

2.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.

Authors:  Christine L Chaffer; Ines Brueckmann; Christina Scheel; Alicia J Kaestli; Paul A Wiggins; Leonardo O Rodrigues; Mary Brooks; Ferenc Reinhardt; Ying Su; Kornelia Polyak; Lisa M Arendt; Charlotte Kuperwasser; Brian Bierie; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-15       Impact factor: 11.205

3.  Slug and Sox9 cooperatively determine the mammary stem cell state.

Authors:  Wenjun Guo; Zuzana Keckesova; Joana Liu Donaher; Tsukasa Shibue; Verena Tischler; Ferenc Reinhardt; Shalev Itzkovitz; Aurelia Noske; Ursina Zürrer-Härdi; George Bell; Wai Leong Tam; Sendurai A Mani; Alexander van Oudenaarden; Robert A Weinberg
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

4.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

5.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

6.  Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

Authors:  Sarah Schwitalla; Alexander A Fingerle; Patrizia Cammareri; Tim Nebelsiek; Serkan I Göktuna; Paul K Ziegler; Ozge Canli; Jarom Heijmans; David J Huels; Guenievre Moreaux; Rudolf A Rupec; Markus Gerhard; Roland Schmid; Nick Barker; Hans Clevers; Roland Lang; Jens Neumann; Thomas Kirchner; Makoto M Taketo; Gijs R van den Brink; Owen J Sansom; Melek C Arkan; Florian R Greten
Journal:  Cell       Date:  2012-12-27       Impact factor: 41.582

7.  Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.

Authors:  Piyush B Gupta; Christine M Fillmore; Guozhi Jiang; Sagi D Shapira; Kai Tao; Charlotte Kuperwasser; Eric S Lander
Journal:  Cell       Date:  2011-08-19       Impact factor: 41.582

8.  Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity.

Authors:  Christine L Chaffer; Nemanja D Marjanovic; Tony Lee; George Bell; Celina G Kleer; Ferenc Reinhardt; Ana C D'Alessio; Richard A Young; Robert A Weinberg
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

9.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 10.  Cells of origin in cancer.

Authors:  Jane E Visvader
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

  10 in total
  63 in total

Review 1.  Mitostemness.

Authors:  Elisabet Cuyàs; Sara Verdura; Núria Folguera-Blasco; Cristian Bastidas-Velez; Ángel G Martin; Tomás Alarcón; Javier A Menendez
Journal:  Cell Cycle       Date:  2018-07-02       Impact factor: 4.534

Review 2.  Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract.

Authors:  Jason C Mills; Owen J Sansom
Journal:  Sci Signal       Date:  2015-07-14       Impact factor: 8.192

Review 3.  Peptides encoded by noncoding genes: challenges and perspectives.

Authors:  Shuo Wang; Chuanbin Mao; Shanrong Liu
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

Review 4.  Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

Authors:  R Servín-Blanco; R Zamora-Alvarado; G Gevorkian; K Manoutcharian
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

Review 5.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

6.  Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.

Authors:  Lei Li; Jiang-Chao Li; Hong Yang; Xu Zhang; Lu-Lu Liu; Yan Li; Ting-Ting Zeng; Ying-Hui Zhu; Xiao-Dong Li; Yan Li; Dan Xie; Li Fu; Xin-Yuan Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-29       Impact factor: 11.205

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

8.  Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.

Authors:  Bin Bao; Emily A Teslow; Cristina Mitrea; Julie L Boerner; Greg Dyson; Aliccia Bollig-Fischer
Journal:  Mol Cancer Res       Date:  2020-09-10       Impact factor: 5.852

Review 9.  Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.

Authors:  Derek V Seidel; M Andrea Azcárate-Peril; Robert S Chapkin; Nancy D Turner
Journal:  Semin Cancer Biol       Date:  2017-07-01       Impact factor: 15.707

10.  A MASCOT for mosaic analysis.

Authors:  Yan Yan; Tuomas Tammela
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.